FWIW, this PR was one of Paul's best, as he walked the tightrope really well in regard to:
a. the reduction in the growth rate of sales is balanced off by the growth in gross margin percentage; and
b. the company is doing all it can to live as well as it can with the new FDA regs for these initial two years while waiting for the FDA to relent in ceding the vaping field to Big Tobacco.
My personal opinion is that a Trump election will bring the FDA to the bargaining table with industry representatives.
As an aside, the introduction of Kelly Winther as a force within the company is a good move in my opinion, and I wonder if there's a connection between her arrival and the reduction in expenses mentioned in the PR. Let's see whether an 8K will be devoted to her stock ownership.
Have a good week, Hostastock!
News 
Market Data 
Discover 
